2.16.840.1.113883.5.1070

Hinweis zu dieser Seite

Kodesystem substanceAdminSubstitution

Beschreibung

Identifies what sort of change is permitted or has occurred between the therapy that was ordered and the therapy that was/will be provided.

Aktuelle Version

Codesystem Name		Codesystem Id	Version / Eingangsdatum	Status
substanceAdminSubstitution		2.16.840.1.113883.5.1070	2012-07-24	definitiv
Level/Typ	Code	Anzeigename	Beschreibung
0-A	_ActSubstanceAdminSubstitutionCode	ActSubstanceAdminSubstitutionCode	Description: Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects.
1-S	E	equivalent	Description: Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.
2-S	EC	equivalent composition	Description: Substitution occurred or is permitted with another product that is a: pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration Examples: Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate Pharmaceutical equivalent: Lisonpril for Zestril
3-L	BC	brand composition	Description: Substitution occurred or is permitted between equivalent Brands but not Generics Examples: Zestril for Prinivil Coumadin for Jantoven
3-L	G	generic composition	Description: Substitution occurred or is permitted between equivalent Generics but not Brands Examples: Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)
2-S	TE	therapeutic alternative	Description: Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile. Examples: ranitidine for Tagamet
3-L	TB	therapeutic brand	Description: Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics> Examples: Zantac for Tagamet
3-L	TG	therapeutic generic	Description: Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands> Examples: Ranitidine for cimetidine
1-L	F	formulary	Description: This substitution was performed or is permitted based on formulary guidelines.
1-L	N	none	No substitution occurred or is permitted.

Verwendung in Value Sets

• 2.16.840.1.113883.1.11.16621 ActSubstanceAdminSubstitutionCode (2012-07-24)

Zusammenstellung aller Versionen dieses Kodesystems

• 2012-07-24